Human Monkeypox : Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention - 25/10/19

Doi : 10.1016/j.idc.2019.03.001

Eskild Petersen, MD, DMSc, DTMH ^a,^b,^c,^⁎ , Anu Kantele, MD, PhD ^d, Marion Koopmans, DVM, PhD ^e, Danny Asogun, MBBS, FWACP ^f,^g, Adesola Yinka-Ogunleye, BDS, MPH ^h, Chikwe Ihekweazu, MBBS, MPH, FFPH ^h, Alimuddin Zumla, MBChB, MSc, PhD, MD, FRCP(Lond), FRCP(Edin), FRCPath(UK), FAAS ⁱ
^a Institute of Clinical Medicine, University of Aarhus, Palle Juul-Jensens Boulevard 82, Aarhus N DK-8200, Denmark
^b The Royal Hospital, Muscat, Oman
^c European Society for Clinical Microbiology and Infectious Diseases, Task Force for Emerging Infections, Basel, Switzerland
^d Inflammation Center, Helsinki University Hospital and Helsinki University, Stenbäckinkatu 9, PO BOX 100, Helsinki FI-00029 HUS, Finland
^e Viroscience Department, Erasmus Medical Centre, Postbus 2040, Rotterdam 3000 CA, the Netherlands
^f Department of Public Health, College of Medicine, Ambrose Alli University, Ekpoma, Nigeria
^g Department of Public Health, and Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria
^h Nigeria Centre for Disease Control, Plot 801, Ebitu Ukiwe Street, Jabi, Abuja, Nigeria
ⁱ Division of Infection and Immunity, Center for Clinical Microbiology, University College London, The National Institute of Health Research Biomedical Research Centre at UCL Hospitals, Gower Street, London WC1E 6BT, UK

^∗Corresponding author. Directorate General for Communicable Disease Surveillance and Control, Ministry of Health, 18th November Street, 101 Muscat, Sultanate of Oman.Directorate General for Communicable Disease Surveillance and ControlMinistry of Health18th November Street, 101 MuscatSultanate of Oman

Résumé

Recently, concern has been raised about the emergence of human monkeypox virus and the occasionally severe clinical presentation bearing resemblance to that of smallpox. In 2018 3 patients in the UK were diagnosed with monkeypox, and the frequency and geographic distribution of cases across West and Central Africa have increased in recent years. In Nigeria, most monkeypox patients are aged <40 years and lack cross-protective immunity because they were born after discontinuation of the smallpox eradication campaign. This article reviews the epidemiology, clinical features, and management of monkeypox and discusses its growing public health threat in this context.

Le texte complet de cet article est disponible en PDF.

Keywords : Monkeypox, Smallpox, West Africa, Epidemic

Plan

	All authors contributed equally.
	A. Zumla, D. Asogun, and C. Ihekweazu are members of the PANDORA-ID-NET Consortium. PANDORA-ID-NET (EDCTP Reg/Grant RIA2016E-1609) is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP2) programme, which is supported under Horizon 2020, the European Union's Framework Programme for Research and Innovation. A. Zumla is in receipt of a National Institutes of Health Research senior investigator award.
	Conflicts of Interest: All authors have an interest in global public health and emerging and re-emerging infections. All authors have no other conflict of interest to declare.

Export

Vol 33 - N° 4

P. 1027-1043 - décembre 2019 Retour au numéro

Article précédent

Chikungunya : Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention
Francesco Vairo, Najmul Haider, Richard Kock, Francine Ntoumi, Giuseppe Ippolito, Alimuddin Zumla

| Article suivant

Viral Hepatitis : Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention
Simone Lanini, Andrew Ustianowski, Raffaella Pisapia, Alimuddin Zumla, Giuseppe Ippolito

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Human Monkeypox : Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention - 25/10/19

Résumé

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL